Jiarui Wu

Dr. Jiarui Wu


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Cancer Cell
Verified
Journal Article
Closed access
CLChen Li
Chen Li
YSYi-Di Sun
Yi-Di Sun
GYGuanyu Yu
Guanyu Yu
JCJing-Ru Cui
Jing-Ru Cui
ZLZheng Lou
Zheng Lou
RZRong Zeng
Rong Zeng

7 July 2016 in Diabetes Care
Verified
Journal Article
Open access
PDF file
LSLiang Sun
Liang Sun
LLLiming Liang
Liming Liang
XGXianfu Gao
Xianfu Gao
HZHuiping Zhang
Huiping Zhang
PYPang Yao
Pang Yao
JWJiarui Wu
Jiarui Wu
OBJECTIVE: Acylcarnitines were suggested as early biomarkers even prior to insulin resistance in animal studies, but their roles in predicting type 2 diabetes were unknown. Therefore, we aimed to determine whether acylcarnitines could independently predict type 2 diabetes by using a targeted metabolic profiling approach. RESEARCH DESIGN AND METHODS: A population-based prospective study was conducted among 2,103 community-living Chinese individuals aged 50–70 years from Beijing and Shanghai with a mean follow-up duration of 6 years. Fasting glucose, glycohemoglobin, and insulin were determined at baseline and in a follow-up survey. Baseline plasma acylcarnitines were profiled by liquid chromatography–tandem mass spectrometry. RESULTS: Over the 6-year period, 507 participants developed diabetes. A panel of acylcanitines, especially with long chain, was significantly associated with increased risk of type 2 diabetes. The relative risks of type 2 diabetes per SD increase of the predictive model score were 2.48 (95% CI 2.20–2.78) for the conventional and 9.41 (95% CI 7.62–11.62) for the full model including acylcarnitines, respectively. Moreover, adding selected acylcarnitines substantially improved predictive ability for incident diabetes, as area under the receiver operator characteristic curve improved to 0.89 in the full model compared with 0.73 in the conventional model. Similar associations were obtained when the predictive models were established separately among Beijing or Shanghai residents. CONCLUSIONS: A panel of acylcarnitines, mainly involving mitochondrial lipid dysregulation, significantly improved predictive ability for type 2 diabetes beyond conventional risk factors. These findings need to be replicated in other populations, and the underlying mechanisms should be elucidated.

15 November 2010 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
KZKunming Zhang
Kunming Zhang
WGWei Guo
Wei Guo
YYYing Yang
Ying Yang
JWJiarui Wu
Jiarui Wu

1 October 2020 in Advanced Science
Verified
Journal Article
Open access
PDF file
QXQiuhui Xuan
Qiuhui Xuan
YOYang Ouyang
Yang Ouyang
YWYanfeng Wang
Yanfeng Wang
LWLiang Wu
Liang Wu
HLHuating Li
Huating Li
Guowang XuGuowang Xu
Guowang Xu
Diabetic retinopathy (DR) is the main cause of vision loss or blindness in working age adults worldwide. The lack of effective diagnostic biomarkers for DR leads to unsatisfactory curative treatments. To define potential metabolite biomarkers for DR diagnosis, a multiplatform‐based metabolomics study is performed. In this study, a total of 905 subjects with diabetes without DR (NDR) and with DR at different clinical stages are recruited. Multiplatform metabolomics methods are used to characterize the serum metabolic profiles and to screen and validate the DR biomarkers. Based on the criteria p < 0.05 and false‐discovery rate < 0.05, 348 and 290 metabolites are significantly associated with the pathogenesis of DR and early‐stage DR, respectively. The biomarker panel consisting of 12‐hydroxyeicosatetraenoic acid (12‐HETE) and 2‐piperidone exhibited better diagnostic performance than hemoglobin A1c (HbA1c) in differentiating DR from diabetes, with AUCs of 0.946 versus 0.691 and 0.928 versus 0.648 in the discovery and validation sets, respectively. In addition, this panel showed higher sensitivity in early‐stage DR detection than HbA1c. In conclusion, this multiplatform‐based metabolomics study comprehensively revealed the metabolic dysregulation associated with DR onset and progression. The defined biomarker panel can be used for detection of DR and early‐stage DR.

1 July 2004 in Journal of Molecular Biology
Verified
Journal Article
Closed access
RZRong Zeng
Rong Zeng
Ruifu YangRuifu Yang
Ruifu Yang
MSMu-De Shi
Mu-De Shi
MJMan-Rong Jiang
Man-Rong Jiang
YXYou-Hua Xie
You-Hua Xie
JWJiarui Wu
Jiarui Wu

2 October 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
ZSZhendong Sun
Zhendong Sun
YSYuzhuo Shao
Yuzhuo Shao
KYKunhao Yan
Kunhao Yan
TYTianzhao Yao
Tianzhao Yao
LLLulu Liu
Lulu Liu
YHYunpeng Huang
Yunpeng Huang
Trace metal elements are of vital importance for fundamental biological processes. They function in various metabolic pathways after the long evolution of living organisms. Glucose is considered to be one of the main sources of biological energy that supports biological activities, and its metabolism is tightly regulated by trace metal elements such as iron, zinc, copper, and manganese. However, there is still a lack of understanding of the regulation of glucose metabolism by trace metal elements. In particular, the underlying mechanism of action remains to be elucidated. In this review, we summarize the current concepts and progress linking trace metal elements and glucose metabolism, particularly for the trace metal elements zinc, copper, manganese, and iron.